Cellular Fate of a Modular DNA Delivery System Mediated by Silica Nanoparticles

Development of efficient molecular medicines, including gene therapeutics, RNA therapeutics, and DNA vaccines, depends on efficient means of transfer of DNA or RNA into the cell. Potential problems, including toxicity and immunogenicity, surrounding viral methods of DNA delivery have necessitated the use of nonviral, synthetic carriers. To better design synthetic carriers, or transfection reagents, the modular design of viruses has inspired a modular approach to DNA and RNA delivery. Each modular component can be designed to circumvent each of the many barriers. The modular approach will allow modification of individual components for a specific application. By utilizing a dense silica nanoparticle to form a ternary complex, transfection efficiency of a DNA‐transfection reagent complex was increased by a factor of approximately 10 by concentrating the DNA at the surface of cells. Surface modification of the silica nanoparticles allowed determination of the cellular uptake mechanism with only minor alteration of transfection efficiency. Nanoparticles are internalized by an endosome‐lysosomal route followed by perinuclear accumulation. The modification mechanism confirms that surface modification of the modular system can allow specific moieties to be incorporated into the modular system without significant alteration of the transfection efficiency. By showing that the modular system based upon concentration of DNA at the level of the cell can be used to increase transfection efficiency, we have shown that further modification of the system may better target DNA delivery and overcome other barriers of DNA expression.

[1]  T. Schiestel,et al.  A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. , 2000, Bioconjugate chemistry.

[2]  L. Seymour,et al.  Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.

[3]  C. K. Chan,et al.  Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. , 1999, Human gene therapy.

[4]  D. Luo,et al.  A self-assembled, modular DNA delivery system mediated by silica nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Mark Saltzman,et al.  Enhancement of transfection by physical concentration of DNA at the cell surface , 2000, Nature Biotechnology.

[7]  A. Phillips The challenge of gene therapy and DNA delivery , 2001, The Journal of pharmacy and pharmacology.

[8]  R. Gemeinhart,et al.  Assessment of a modular transfection system based upon cellular localization of DNA. , 2004, Molecular pharmaceutics.

[9]  Seymour,et al.  Key issues in non-viral gene delivery. , 2001, Advanced drug delivery reviews.

[10]  S. Moore,et al.  Photometric ninhydrin method for use in the chromatography of amino acids. , 1948, The Journal of biological chemistry.

[11]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[12]  F. Szoka,et al.  Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.

[13]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[14]  T. Schiestel,et al.  Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. , 2000, International journal of pharmaceutics.

[15]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.